experimental model
focal segmental glomerular sclerosis
FSGS
rats
administration
puromycin-aminonucleoside
AMNS
protamine sulfate
PS
Male
Sprague-Dawley rats
uninephrectomized
weeks
daily
injections
subcutaneous
AMNS
intravenous PS
doses
days
injections
day
intervals
animals
sacrificed
days
nephrotic syndrome
renal failure
time-course curve
creatinine clearance
significant
control group
AMNS
PS
saline
injected
glomeruli
progressive
FSGS
ultrastructural studies
initial stage
particles
perfused
ruthenium red
lamina rara externa
epithelial cell
cytoplasm
administration
PS
toxicity
AMNS
glomerulus
progressive
FSGS
rats
end-stage renal disease
